Familial hypercholesterolaemia and emerging therapeutics

Heart. 2023 Sep 13;109(19):1486-1493. doi: 10.1136/heartjnl-2022-321917.

Authors

Francisco I Farias¹, Samuel M Kim², Michael D Shapiro³

Affiliations

¹ Department of Medicine, University of Washington Medical Center, Seattle, Washington, USA.
² Cardiology, New York-Presbyterian Weill Cornell Medical Center, New York, New York, USA smk9018@med.cornell.edu.
³ Cardiovascular Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.

PMID: 37130749
DOI: 10.1136/heartjnl-2022-321917

No abstract available

Keywords: coronary artery disease; education, medical; hyperlipidemias; pharmacology, clinical.

MeSH terms

Humans
Hyperlipoproteinemia Type II* / diagnosis
Hyperlipoproteinemia Type II* / drug therapy
Hyperlipoproteinemia Type II* / genetics